Evidence map›Paper›PMID 37247186›Full record

ArticleInterdisciplinary sciences, computational life sciences2023

A Self-attention Graph Convolutional Network for Precision Multi-tumor Early Diagnostics with DNA Methylation Data.

Xue Jiang, Zhiqi Li, Aamir Mehmood, Heng Wang, Qiankun Wang, Yanyi Chu, Xueying Mao, Jing Zhao, Mingming Jiang, Bowen Zhao and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Interdisciplinary sciences, computational life sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. AI based multiomics integration for cancer diagnosis and prognosis.Journal, genetic engineering & biotechnology · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xue Jiang *School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.ORCID http://orcid.org/0000-0003-2109-8660
Zhiqi Li *School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Aamir MehmoodSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Heng WangInternational School of Cosmetics, School of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai, China.
Qiankun WangSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Yanyi ChuSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Xueying MaoSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Jing ZhaoSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Mingming JiangSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Bowen ZhaoSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Guanning LinSchool of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Edwin WangDepartment of Biochemistry and Molecular Biology, Medical Genetics, and Oncology, Cumming School of Medicine, University of Calgary, Calgary, Canada. edwin.wang@ucalgary.ca.
Dongqing WeiSchool of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. dqwei@sjtu.edu.cn.

Funding

National Science Foundation of China 32070662
6 · The paper itself

Abstract

DNA methylation-based precision tumor early diagnostics is emerging as state-of-the-art technology that could capture early cancer signs 3 ~ 5 years in advance, even for clinically homogenous groups. Presently, the sensitivity of early detection for many tumors is ~ 30%, which needs significant improvement. Nevertheless, based on the genome-wide DNA methylation data, one could comprehensively characterize tumors' entire molecular genetic landscape and their subtle differences. Therefore, novel high-performance methods must be modeled by considering unbiased information using excessively available DNA methylation data. To fill this gap, we have designed a computational model involving a self-attention graph convolutional network and multi-class classification support vector machine to identify the 11 most common cancers using DNA methylation data. The self-attention graph convolutional network automatically learns key methylation sites in a data-driven way. Then, multi-tumor early diagnostics is realized by training a multi-class classification support vector machine based on the selected methylation sites. We evaluated our model's performance through several data sets of experiments, and our results demonstrate the effectiveness of the selected key methylation sites, which are highly relevant for blood diagnosis. The pipeline of the self-attention graph convolutional network based computational framework.

Indexed as

DNA MethylationNeoplasmsHumansProtein Processing, Post-TranslationalSupport Vector MachineGraph convolutional networkKey methylation sitesMulti-tumor early diagnosticsSelf-attention mechanism

Identifiers

PMID37247186

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.